May 19, 2025，Rehabilitation Nursing CompanyLifeward (NASDAQ: LFWD)Announcement of AppointmentFormer Vice President of Medtronic Americas, Mark GrantFor the company's new appointmentPresident & CEO, sinceJune 2, 2025Officially effective. This appointment marks a critical phase for Lifeward as it transitions from technical validation to commercial growth.

Current CEOLarry JasinskiWill officially retire in the second quarter and serve as Co-CEO with Grant to assist in the transition before the end of June, then continue to serve as a company advisor by the end of the year.

Jasinski has led the company since 2012, drivingReWalk Exoskeleton SystemObtaining FDA Approval and EstablishmentMedicare China-wide Reimbursement Pathway, and led the completion ofIntegration of AlterG's Acquisition, is a key driver in the company's transformation from a single-product enterprise to a diversified rehabilitation platform.

# Background of the New CEO

New CEOMark GrantWith over 30 years of experience in the medical technology field,Long-term focus onCommercialization of Medical Devices, Channel Development, and Team Management，Once inMedtronicAndIMRA SurgicalHeld senior executive positions at companies such as Medtronic, Lifeward, and ReWalk Robotics, Ltd.

InIMRA Surgical（2023–2025）, Grant serves as the President of the Americas and Chief Commercial Officer, responsible for driving the commercialization of ethical surgical training technologies.Strategy, established a multi-channel sales system, and participated in capital raising and corporate development planning.

Previously inMedtronic (2004–2023)Served for nearly 20 years, eventually serving as the Vice President of the Americas, leading the payment strategy and market access for diabetes home care services. The cross-functional team led by him coversSales, Clinical Support, Health Economics, Reimbursement, Customer Service and MarketingSuch key departments have rich experience in cross-regional management.

He onceInBristol Myers Squibb、FLA OrthopedicsHeld early positions at companies such asBachelor of Industrial Technology, East Carolina UniversityChairman of the Board, LifewardJoseph TurkEvaluate it as "Result-Oriented Leader"Medtronic emphasizes its role in promoting the implementation of medical insurance, commercial insurance, and workers' compensation pathways."Facing Ability.

# Why Choose Lifeward?

As a senior executive who once managed Medtronic's Americas business, why did Mark Grant choose to join a rehabilitation technology company with annual revenue of only over twenty million dollars and still in the red?

• The Rehabilitation Technology Industry Is Experiencing a Strategic Return
  

• ReWalk SystemAlready obtainedMedicare China-wide Reimbursement Mechanism, as of the first quarter of 2025, the company has submitted to MedicareMore than 120 qualified cases, partially approved. In April 2025, the company obtainedFirst Commercial Insurance Coverage Case, marking the beginning of the commercial insurance sector.

• 

• AlterG SystemTo launch a new model in 2024 after completing the integrationAlterG NEO, suitable for small and medium-sized clinics and home rehabilitation environments. The product has received approximately 40 orders, with revenue in the first quarter of 2025 increasing year-over-year.17%。

• Exoskeletons and anti-gravity rehabilitation devices are moving from the initial validation phase into the implementation phase of medical insurance and payment mechanisms. The inclusion of ReWalk in Medicare and the recovery growth of AlterG mark a simultaneous increase in industry demand and willingness to pay.

• 
  

• Product portfolio possesses completeness and growth potential.
  

  

• Lifeward hasReWalk, AlterG, MyoCycle, and ReStoreFour core products, coveringNeurological Rehabilitation, Orthopedic Postoperative Rehabilitation and Home Training, and runs through the entire rehabilitation pathway from hospital to community, with the potential to increase customer spending and long-term repurchase.

  
  

• Commercial Pathway Overlaps with Grant's Professional Expertise
  

  CompanyRevenue in 2024 was $25.7 million, an 85% increase year-over-year.Specific guidance for 2025 has not been provided yet, but it is expected to grow to the range of $28 million–$30 million. The company explicitly stated that it will significantly narrow its non-GAAP operating loss by 2025 through revenue growth and cost optimization, moving towards profitability.

  Lifeward is currently in need ofAn executive manager who is familiar with the reimbursement system, payer communication, and channel development. Grant promoted during his time at Medtronic.The experience of product commercial pathway implementation is directly applicable to the company's current stage tasks.

  
  

• Career Stage Matching
  

  For a senior executive, joining a company with a established product structure, preliminary market mechanisms in place but still awaiting amplification, isFrom Operation-led to Strategy-driven TransformationThe Typical PathPath.

In short, this is an executive's view of a“Basic framework has been completed, barriers have not yet solidified."The growth potential of enterprises is also reflected in the gradual unfolding of the secondary value discovery in the rehabilitation equipment market.

# CompanyCore Product

Focus of Lifeward's ProductsNerve Injury, Orthopedic Rehabilitation, Sports Training and Home CareFour Core Areas, Covering Multiple Scenarios Including Inpatient, Outpatient, and Home:

ReWalk Personal Exoskeleton

• Gait Recovery Device for People with Spinal Cord Injury, the New Generation ReWalk 7 to be Launched in April 2025.

• FDA approved and included in Medicare national reimbursement, with the first commercial insurance payment support in 2025.

• Features personalized gait adjustment, multi-sensor fusion control, and other technical characteristics.

• Sales increased by 130% in 2024, and international markets such as Germany's BARMER have also been covered.

  
  

AlterG Anti-Gravity System

• Using differential pressure technology to provide partial weight reduction for walking and running training, applicable toRehabilitation Training for Orthopedic Surgery, Stroke, Parkinson's Disease, etc.。

• Launch lightweight product AlterG NEO in 2024, expanding into small and medium-sized clinics and the home market.

• Revenue in Q1 2025 increased by 17% year-over-year, with orders showing steady growth.

  
  

ReStore Exoskeleton Suit

• Flexible Structure, Lightweight Gait Support System for Walking Training in Stroke Patients, Mainly Applied in Hospital Rehabilitation Departments.

• Combine real-time gait analysis with personalized power output to enhance training effectiveness.

  
  

MyoCycle Functional Electrical Stimulation System

• Combining stationary bicycles with FES technology to activate lower limb muscle groups, improving circulation and muscle tone.

• Including MyoCycle Pro (Clinical) and the home version product; the latter enters the home rehabilitation market through cooperation with MYOLYN.

• Sales Channel Optimization in 2025: Coverage Expanded to Include Veterans and Workers' Compensation Populations.

# About Lifeward

Lifeward (formerly ReWalk Robotics) was founded in 2001 and is headquartered inMarlborough, Massachusetts, USA, inElite Yorkneum, IsraelHas a research and development center and an operating institution in Germany. The company completed its brand reshaping in 2023, forming a...Multi-Product Rehabilitation Platform Focused on Functional Recovery。